review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Ernest Dallé | Q90149231 |
P2093 | author name string | Musa V Mabandla | |
William M U Daniels | |||
P2860 | cites work | Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target. | Q50039451 |
High performance plasma amyloid-β biomarkers for Alzheimer's disease | Q50107488 | ||
A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication. | Q51760901 | ||
A practical analysis of the electrical conductivity of blood. | Q52707582 | ||
Dielectric properties of human blood and erythrocytes at radio frequencies (0.2?10 MHz); dependence on cell volume fraction and medium composition | Q56975016 | ||
Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease | Q64360652 | ||
Dielectric properties of human blood at microwave frequencies | Q72924398 | ||
Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease | Q90980821 | ||
Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease | Q91030167 | ||
Familial Alzheimer's disease-linked presenilin mutants and intracellular Ca2+ handling: A single-organelle, FRET-based analysis | Q92045752 | ||
Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta | Q93066085 | ||
Refining memory assessment of elderly people with cognitive impairment: Insights from the short-term memory binding test | Q93179618 | ||
Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity | Q30493579 | ||
Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach | Q31144656 | ||
Biomarkers in translational research of Alzheimer's disease | Q33556189 | ||
Blood-based biomarkers of microvascular pathology in Alzheimer's disease | Q33625663 | ||
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans | Q33846034 | ||
3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects | Q33990243 | ||
Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies | Q34160761 | ||
The passive electrical properties of biological systems: their significance in physiology, biophysics and biotechnology | Q34173531 | ||
Identifying and validating biomarkers for Alzheimer's disease | Q34468961 | ||
Amyloid-β immunization enhances neurogenesis and cognitive ability in neonatal mice. | Q35792042 | ||
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors | Q35889850 | ||
The Alzheimer's disease beta-secretase enzyme, BACE1. | Q36397690 | ||
Role of biomarkers in studies of presymptomatic Alzheimer's disease | Q37549214 | ||
Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects | Q37606705 | ||
Alzheimer's disease is incurable but preventable | Q37698040 | ||
Biomarkers for Alzheimer's disease therapeutic trials | Q37815749 | ||
Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine | Q37835982 | ||
Alzheimer's disease: cholesterol a menace? | Q37899391 | ||
Blood and plasma-based proteomic biomarker research in Alzheimer's disease | Q38022421 | ||
Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease | Q38034089 | ||
A review on Alzheimer's disease pathophysiology and its management: an update | Q38364941 | ||
The dielectric properties of biological tissues: I. Literature survey | Q41235855 | ||
Dielectric properties of blood: an investigation of haematocrit dependence | Q42594980 | ||
Mémantine (Ebixa): a new therapeutic strategy for the treatment of moderate to severe forms of Alzheimer's disease | Q44804254 | ||
Dielectric properties of human colostrum at microwave frequencies. | Q46831580 | ||
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease | Q47583762 | ||
Poly-N-methylated Aβ-Peptide C-Terminal fragments (MEPTIDES) reverse the deleterious effects of amyloid-β in rats | Q47673729 | ||
Capsaicin Attenuates Amyloid-β-Induced Synapse Loss and Cognitive Impairments in Mice | Q47985863 | ||
Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease | Q48300537 | ||
Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics | Q48346421 | ||
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study | Q48725577 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | blood plasma | Q79749 |
biomarker | Q864574 | ||
P304 | page(s) | 5756382 | |
P577 | publication date | 2020-02-13 | |
P1433 | published in | Oxidative medicine and cellular longevity | Q26840015 |
P1476 | title | Dielectric Constant and Conductivity of Blood Plasma: Possible Novel Biomarkers for Alzheimer's Disease | |
P478 | volume | 2020 |
Search more.